Skip to content

Investors

Investors

Investors

Welcome to our Investor Center. Our center is designed to provide you with convenient access to company information. For additional information on our portfolio of product candidates, please visit Pipeline.
 

Webcasts
More>>
Webcast ImageWebcast (Replay)
ACADIA Pharmaceuticals at Oppenheimer 25th Annual Healthcare Conference
12/10/14 at 2:10 p.m. ET
ACADIA Pharmaceuticals at Oppenheimer 25th Annual Healthcare Conference
Wednesday, December 10, 2014 2:10 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
 

Recent News
More>>
DateTitle 
12/08/14ACADIA Pharmaceuticals Presents Caregiver Burden Data at the International Congress of Non-Motor Dysfunctions in Parkinson’s Disease and Related Disorders
Data Demonstrate a Decreased Burden Among Caregivers of Patients with Parkinson’s Disease Psychosis Treated with NUPLAZID™ (Pimavanserin) SAN DIEGO--(BUSINESS WIRE)--Dec. 8, 2014-- ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) today announced the presentation of caregiver burden data from its Phase III program with NUPLAZID™ (pimavanserin) for Parkinson’s disease psychosis (PDP) at the 10th Annual International Congress of Non-Motor Dysfunctions ... 
Printer Friendly Version
11/25/14ACADIA Pharmaceuticals to Present at Upcoming Investor Conferences
SAN DIEGO--(BUSINESS WIRE)--Nov. 25, 2014-- ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, today announced that it will present at the following investor conferences: The Piper Jaffray 26th Annual Healthcare Conference on Tuesday, December 2, 2014, at 10:30 a.m. Eastern Time in New Yo... 
Printer Friendly Version
11/13/14ACADIA Pharmaceuticals to Present at Jefferies 2014 Global Healthcare Conference on November 20, 2014
SAN DIEGO--(BUSINESS WIRE)--Nov. 13, 2014-- ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in neurological and related central nervous system disorders, today announced that it will present at the Jefferies 2014 Global Healthcare Conference on Thursday, November 20, 2014, at 9:20 a.m. GMT in London. A live webc... 
Printer Friendly Version
 

Stock Quote
More>>
ACAD (common stock)
ExchangeNASDAQ
Price$32.98
Change (%) Stock is Up 0.14 (0.40%)
Volume2,097,564
12/19/14 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
Minimum 20 minutes delayed
Stay Informed
Corporate Presentation
Request Literature
Scientific Publications
Subscribe to Email Alerts
RSS Feeds
IR Contact
Featured Reports
Lancet Article on Pimavanserin Phase III PDP Trial
Annual Report
Proxy Statement
Parkinson’s Disease Psychosis Backgrounder
back to top